Related references
Note: Only part of the references are listed.HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PIGF
Charlotte Rolny et al.
CANCER CELL (2011)
Combining radiation therapy with interstitial radiation-inducible TNF-α expression for locoregional cancer treatment
M. Jung et al.
CANCER GENE THERAPY (2011)
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
A. Santoro et al.
BRITISH JOURNAL OF CANCER (2010)
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev K. Shrimali et al.
CANCER RESEARCH (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Targeted Liposomal Delivery of TLR9 Ligands Activates Spontaneous Antitumor Immunity in an Autochthonous Cancer Model
Juliana Hamzah et al.
JOURNAL OF IMMUNOLOGY (2009)
Responsiveness of Stromal Fibroblasts to IFN-γ Blocks Tumor Growth via Angiostasis
Yu Lu et al.
JOURNAL OF IMMUNOLOGY (2009)
Polarized immune responses differentially regulate cancer development
Magnus Johansson et al.
IMMUNOLOGICAL REVIEWS (2008)
Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice
Juliana Hamzah et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNγ
Anna Maria Gasparri et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Juliana Hamzah et al.
NATURE (2008)
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
Christian Stockmann et al.
NATURE (2008)
Tumor necrosis factor α mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response
Ann L. B. Seynhaeve et al.
CANCER RESEARCH (2007)
Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
Christopher Daly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tumor growth or regression: powered by inflammation
Delia Nelson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Targeted delivery of tumor necrosis factor-α to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin
E Balza et al.
CLINICAL CANCER RESEARCH (2006)
Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors
Anita E. M. Dirkx et al.
FASEB JOURNAL (2006)
Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation
U Fiedler et al.
NATURE MEDICINE (2006)
Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas
HWM van Laarhoven et al.
INVESTIGATIONAL NEW DRUGS (2006)
Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy
C Ebbinghaus et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Targeted delivery of IFNγ to tumor vessels uncouples antitumor from counterregulatory mechanisms
F Curnis et al.
CANCER RESEARCH (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction
N Garbi et al.
JOURNAL OF IMMUNOLOGY (2004)
Selective targeted delivery of TNFα to tumor blood vessels
L Borsi et al.
BLOOD (2003)
The role of the microtubules in tumor necrosis factor-α-induced endothelial cell permeability
I Petrache et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis
JA Joyce et al.
CANCER CELL (2003)
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
F Curnis et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
F Curnis et al.
NATURE BIOTECHNOLOGY (2000)
Share Paper
